Portfolio of Biotech Stocks: Diabetes
Here is a sample of 5 biotech stocks that provide diabetes treatments.
|5 Biotech Stocks: Diabetes|
Stock Returns & Price Chart
Recent Prices &
|Tandem Diabetes Care||TNDM|
|Price data from Quandl as of most recent close.|
The 4 stocks included in the portfolio
computations are: DXCM, PODD, MNKD and MDT. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. TNDM was excluded from the portfolio computations because of insufficient price data.
To inspect the performance of the Biotech Stocks: Diabetes portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.
The current value of a $10,000 investment is $111,064. The percent return is 1,010.64%. The annualized return is 27.22%.